Cellebrite DI (CLBT) Financials

$11.45

$-0.49 (-4.10%)

As on 04-Sep-2026 16:19EDT

Market cap

$2,878 Mln

Revenue (TTM)

$514 Mln

P/E Ratio

49.8

P/B Ratio

5.4

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	168.96	132.17	102.06	20.58	36.05
Cash Flow from Investing Activities	--	-268.25	-149.47	-22.54	-91.23	45.23
Cash from Financing Activities	--	29.64	20.65	21.77	13.97	-68.40
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.23	0.31	-1.14	-0.42	0.63	0.36
Cash EPS ($)	0.23	0.36	-1.10	-0.37	0.67	0.39
Adjusted Book Value ($)	2.15	1.93	1.36	0.18	0.38	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.67	0.53	0.52	0.11	0.18
Free Cash Flow per Share ($)	--	0.62	0.49	0.48	0.06	0.14

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	18.34	-143.18	-117.91	1,522.05	-1,496.30
ROE (%)	11.49	19.10	-152.88	-150.08	46,642.86	-1,496.30
ROA (%)	4.80	9.61	-46.26	-17.33	32.51	20.28
EBIT Margin (%)	17.71	19.17	-68.78	-23.20	44.67	33.49
Net Margin (%)	11.43	16.47	-70.54	-24.95	44.63	28.99
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	17.76	0.19	0.23	0.20	0.10	0.26
EBIT Growth (%)	136.37	133.05	-265.88	-162.38	46.63	623.51
Net Profit Growth (%)	138.93	127.68	-248.96	-167.13	69.20	1,135.01
EPS Growth (%)	130.53	1.27	-1.74	-1.67	0.75	10.61
Book Value Growth (%)	29.77	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	49.78	57.89	-19.25	-20.76	6.96	22.36
Price / Book Value	5.42	9.36	16.22	49.22	11.38	-21.77
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	24.19	39.98	-18.89	-21.33	5.17	15.82
Close Price ($)	14.60	18.03	22.03	8.66	4.36	8.02
High Price ($)	19.98	26.30	22.91	8.85	8.31	13.24
Low Price ($)	11.02	13.10	7.91	4.26	3.80	7.66
Market Cap ($ Cr)	2,877.85	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.05	0.03	0.41	0.21	--
Short term debt to equity ratio	0.01	0.01	0.01	0.15	0.07	--
Current Ratio	1.60	1.56	1.92	1.66	1.42	1.46
Quick Ratio	1.58	1.54	1.89	1.62	1.38	1.43
Interest Coverage	--	174.38	-0.79	-534.91	811.47	538.94

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	21.54	22.07	20.53	23.77	29.10	27.41
Asset Turnover	0.42	0.58	0.66	0.69	0.73	0.70
Receivable days	--	71.92	72.66	87.65	98.69	99.25
Inventory Days	--	40.19	55.08	69.01	60.05	48.34
Payable days	--	67.81	56.48	44.24	50.95	61.25
Cash Conversion Cycle	--	44.30	71.26	112.42	107.80	86.34

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.